neostigmine has been researched along with ANS (Autonomic Nervous System) Diseases in 14 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WILSON, A | 1 |
| MAW, GA | 1 |
| GEOGHEGAN, H | 1 |
| Bawaskar, HS | 1 |
| Bawaskar, PH | 2 |
| Bharucha, AE | 1 |
| Low, PA | 1 |
| Camilleri, M | 1 |
| Burton, D | 1 |
| Gehrking, TL | 1 |
| Zinsmeister, AR | 1 |
| Cellini, J | 1 |
| DiNovo, K | 1 |
| Harlow, J | 1 |
| LePard, KJ | 1 |
| Calvet, X | 1 |
| Martinez, JM | 1 |
| Martinez, M | 1 |
| HERZFELD, E | 1 |
| STUMPF, C | 1 |
| MUHLBERGER, F | 2 |
| SIEDEK, H | 2 |
| STEFENELLI, N | 1 |
| WEWALKA, F | 1 |
| MAYER, J | 1 |
| MARGGRAF, W | 1 |
| SMITH, AA | 1 |
| DANCIS, J | 1 |
| BREININ, G | 1 |
| GOLDSTEIN, A | 1 |
| KRAYER, O | 1 |
| Laothong, C | 1 |
| Sitprija, V | 1 |
| Triantafillou, AN | 1 |
| Tsueda, K | 1 |
| Berg, J | 1 |
| Wieman, TJ | 1 |
1 trial available for neostigmine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Pilot study of pyridostigmine in constipated patients with autonomic neuropathy.
Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Cholinesterase | 2008 |
13 other studies available for neostigmine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Cholinesterase inhibition and signs and symptoms in myasthenia gravis.
Topics: Autonomic Nervous System Diseases; Cholinesterases; Humans; Myasthenia Gravis; Neostigmine; Phosphor | 1951 |
Premonitory signs and symptoms of envenoming by common krait (Bungarus caeruleus).
Topics: Adult; Animals; Atropine; Autonomic Nervous System Diseases; Bulbar Palsy, Progressive; Bungarus; Ch | 2014 |
Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.
Topics: Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2011 |
Repeated neostigmine dosage as palliative treatment for chronic colonic pseudo-obstruction in a patient with autonomic paraneoplastic neuropathy.
Topics: Autonomic Nervous System Diseases; Chronic Disease; Colonic Pseudo-Obstruction; Humans; Male; Middle | 2003 |
[Studies on cholinesterase inhibiting effects of polymethylene-bis-(N-methyl-carbamic acid-m-trimethylammoniumphenols)].
Topics: Autonomic Nervous System Diseases; Carbamates; Cholinesterase Inhibitors; Neostigmine | 1956 |
[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris].
Topics: Angina Pectoris; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cholinesterase Inhibito | 1956 |
[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris].
Topics: Angina Pectoris; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cholinesterase Inhibito | 1956 |
[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris].
Topics: Angina Pectoris; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cholinesterase Inhibito | 1956 |
[The effect of new cholinesterase retarding substance on sympathicotonic circulation disorder, with special reference to angina pectoris].
Topics: Angina Pectoris; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cholinesterase Inhibito | 1956 |
[Cholinesterase inhibition in liver diseases by additional loading with BC 51 (ubretid)].
Topics: Autonomic Nervous System Diseases; Cholinesterases; Humans; Liver Diseases; Neostigmine; Pyridinium | 1958 |
[Therapy of neurovegetative irritation states of a sympathicotonic nature with its sequelae].
Topics: Autonomic Nervous System; Autonomic Nervous System Diseases; Neostigmine; Phenobarbital; Skin Diseas | 1960 |
[OBSERVATIONS ON POSTOPERATIVE GASTROINTESTINAL ATONY AFTER STOMACH SURGERY].
Topics: Autonomic Nervous System Diseases; Humans; Hypokalemia; Intestinal Obstruction; Neostigmine; Postgas | 1963 |
OCULAR RESPONSES TO AUTONOMIC DRUGS IN FAMILIAL DYSAUTONOMIA.
Topics: Adolescent; Autonomic Agents; Autonomic Nervous System Diseases; Child; Cocaine; Corneal Ulcer; Dysa | 1965 |
Plasma neostigmine levels and cholinesterase inhibition in dogs and myasthenic patients.
Topics: Animals; Autonomic Nervous System Diseases; Cholinesterases; Dogs; Humans; Myasthenia Gravis; Neosti | 1949 |
Decreased parasympathetic activities in Malayan krait (Bungarus candidus) envenoming.
Topics: Adult; Animals; Autonomic Nervous System Diseases; Brain Damage, Chronic; Bungarus; Child; Female; H | 2001 |
Refractory bradycardia after reversal of muscle relaxant in a diabetic with vagal neuropathy.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Bradycardia; Diabetic Neuropathies; Glycopyrrolat | 1986 |